Head and Neck Neoplasms, Radiation, Thoracic Neoplasms, Tobacco Use Disorder
Conditions
Keywords
Smoking cessation, Head and neck neoplasms, Lung neoplasms, Thoracic neoplasms, Radiation
Brief summary
Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.
Interventions
OTHERComprehensive smoking cessation intervention
BEHAVIORALEnhanced usual care
Sponsors
National Institute of Dental and Craniofacial Research (NIDCR)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 105 Years
Healthy volunteers
No
Inclusion criteria
* New diagnosis of head and neck or thoracic (including lung) cancer * Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks * English-speaking and able to provide informed consent * Smoked any cigarettes in previous 14 days
Exclusion criteria
* Palliative radiation * Undergoing stereotactic radiosurgery * Pregnant or breastfeeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Smoking cessation | 8 weeks | Smoking cessation will be defined as BOTH (1) self-reported 7-day abstinence from smoking and (2) exhaled carbon monoxide level of 8 or lower as biochemical confirmation of abstinence. |
Countries
United States
Outcome results
None listed